Build an innovation-driven platform with a leading model
Leading Innovation Platform:
Innovation-driven + Patent protection + Market transformation
By combining independent innovation and collaborative research with domestic and foreign top institutions, explore novel markers, develop innovative technologies and products.
Relying on the management team with extensive experience on patent protection, carry out comprehensive patent protection for innovative markers and developed technical platforms, products and methods
Based on the market barriers and competitive advantages brought by patent barriers, through a marketing strategy combining self-owned domestic and foreign channels and authorized multinational companies, commercialize innovative diagnostic products and technologies globally
By building a novel innovation platform, Shuwen and its top partners in many countries or regions around the world have jointly developed forward-looking innovative diagnostic products, forming an advanced technology development model based on China and facing the world, which brings sustainable innovation capability to Shuwen. CapCord® Pre-Eclampsia detection kit is one of the examples of Shuwen's innovation platform. This kit is a first-in-class and China-originated product developed by Shuwen in cooperation with Yale University based on a novel, patented biomarker "misfolded protein". Shuwen exclusively authorized this product to Perkin Elmer, an international IVD industry giant and a global leader in maternal and infant diagnosis. This transaction was evaluated by McKinsey in its annual report on China's medical technology field as "a typical representative of the new era of global cooperation for Chinese companies in the medical technology industry".